Aorta-targeted diagnostic or medical device modalities.
Brandable interfaces for lung-related diagnostics, devices, and conditions (e.g. asthma and COPD).
Premium digital assets tailored for advanced neurological diagnostics, brain health, or cognitive assessment.
Advanced molecular diagnostics for liver disease (cirrhosis).
Next-gen molecular diagnostics and screening for rapid blood clot detection.
Ebola infectious disease diagnostics and screening.
Eczema and psoriasis rating systems for clinical trials or therapeutic tracking.
Digital anchors for cardiac diagnostics and telemetry platforms.
Advanced molecular diagnostics for Fabry disease.
Advanced molecular diagnostics for gout detection.
Diagnostics or testing kits for inflammatory bowel disease (IBS) and urinary tract infection (UTI).
Advanced molecular diagnostics for lupus detection.
Lymphatic system or lymph node related rating system.
Advanced molecular diagnostics for melanoma skin cancer detection or companion diagnostic.
Diagnostic or testing kits to identify infections of the skin (Staph or MRSA) and throat (Strep).
Heart muscle related interventions or treatments.
Norovirus infectious disease screening for at-risk populations (e.g. cruise ships).
Advanced molecular diagnostics for Polyendocrine Metabolic Ovarian Syndrome (PMOS).
Advanced serological diagnostics and antibody testing platforms.
Tuberculosis (TB) infectious disease testing kit or rapid point-of-care (POC) diagnostic test.
Test kit for detection of THC for applications such as employee/job screening or impairment testing.
Premium digital anchors for next-gen thymic health monitoring and immune system diagnostics.
Advanced thyroid function diagnostics and risk scoring platforms.
Advanced blood vessel diagnostics and risk scoring platforms.
Vaccine titer testing platform or service.
Advanced diagnostics and protective interventions for vein health and blood flow.
Vibrio infectious disease diagnostic testing and public safety warning notifications.